No Data
No Data
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Craig-Hallum Issues a Buy Rating on ScPharmaceuticals (SCPH)
Express News | ScPharmaceuticals Inc - Snda Submission for Scp-111 May Be Delayed
Express News | ScPharmaceuticals Inc - Observes Variability in Scp-111 Product Testing
Jefferies Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Cuts Target Price to $13
Express News | ScPharmaceuticals Inc : Jefferies Cuts Target Price to $13 From $16